AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity

Weiyu Zhang, Xianling Zhang, Huan Wang, Xin Guo, Honggui Li, Ying Wang, Xin Xu, Lyhun Tan, Mara T. Mashek, Chunxiang Zhang, Yingjie Chen, Douglas G. Mashek, Marc Foretz, Chuhong Zhu, Huaijun Zhou, Xu Liu, Benoit Viollet, Chaodong Wu, Yuqing Huo

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

AMP-activated protein kinase (AMPK) is an essential sensor of cellular energy status. Defects in the α2 catalytic subunit of AMPK (AMPKα1) are associated with metabolic syndrome. The current study investigated the role AMPKα1 in the pathogenesis of obesity and inflammation using male AMPKα1-deficent (AMPKα1-/-) mice and their wild-type (WT) littermates. After being fed a high-fat diet (HFD), global AMPKα1 -/- mice gained more body weight and greater adiposity and exhibited systemic insulin resistance and metabolic dysfunction with increased severity in their adipose tissues compared with their WT littermates. Interestingly, upon HFD feeding, irradiated WT mice that received the bone marrow of AMPKα1-/- mice showed increased insulin resistance but not obesity, whereas irradiated AMPKα1-/- mice with WT bone marrow had a phenotype of metabolic dysregulation that was similar to that of global AMPKα1-/- mice. AMPKα1 deficiency in macrophages markedly increased the macrophage proinflammatory status. In addition, AMPKα1 knockdown enhanced adipocyte lipid accumulation and exacerbated the inflammatory response and insulin resistance. Together, these data show that AMPKα1 protects mice from diet-induced obesity and insulin resistance, demonstrating that AMPKα1 is a promising therapeutic target in the treatment of the metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)3114-3125
Number of pages12
JournalDiabetes
Volume61
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

AMP-Activated Protein Kinases
Insulin Resistance
Obesity
Diet
High Fat Diet
Bone Marrow
Macrophages
Adiposity
Adipocytes
Adipose Tissue
Catalytic Domain
Body Weight
Inflammation
Phenotype
Lipids
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. / Zhang, Weiyu; Zhang, Xianling; Wang, Huan; Guo, Xin; Li, Honggui; Wang, Ying; Xu, Xin; Tan, Lyhun; Mashek, Mara T.; Zhang, Chunxiang; Chen, Yingjie; Mashek, Douglas G.; Foretz, Marc; Zhu, Chuhong; Zhou, Huaijun; Liu, Xu; Viollet, Benoit; Wu, Chaodong; Huo, Yuqing.

In: Diabetes, Vol. 61, No. 12, 01.12.2012, p. 3114-3125.

Research output: Contribution to journalArticle

Zhang, W, Zhang, X, Wang, H, Guo, X, Li, H, Wang, Y, Xu, X, Tan, L, Mashek, MT, Zhang, C, Chen, Y, Mashek, DG, Foretz, M, Zhu, C, Zhou, H, Liu, X, Viollet, B, Wu, C & Huo, Y 2012, 'AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity', Diabetes, vol. 61, no. 12, pp. 3114-3125. https://doi.org/10.2337/db11-1373
Zhang, Weiyu ; Zhang, Xianling ; Wang, Huan ; Guo, Xin ; Li, Honggui ; Wang, Ying ; Xu, Xin ; Tan, Lyhun ; Mashek, Mara T. ; Zhang, Chunxiang ; Chen, Yingjie ; Mashek, Douglas G. ; Foretz, Marc ; Zhu, Chuhong ; Zhou, Huaijun ; Liu, Xu ; Viollet, Benoit ; Wu, Chaodong ; Huo, Yuqing. / AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. In: Diabetes. 2012 ; Vol. 61, No. 12. pp. 3114-3125.
@article{24aa54a531c84f468641e29517f3e0e0,
title = "AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity",
abstract = "AMP-activated protein kinase (AMPK) is an essential sensor of cellular energy status. Defects in the α2 catalytic subunit of AMPK (AMPKα1) are associated with metabolic syndrome. The current study investigated the role AMPKα1 in the pathogenesis of obesity and inflammation using male AMPKα1-deficent (AMPKα1-/-) mice and their wild-type (WT) littermates. After being fed a high-fat diet (HFD), global AMPKα1 -/- mice gained more body weight and greater adiposity and exhibited systemic insulin resistance and metabolic dysfunction with increased severity in their adipose tissues compared with their WT littermates. Interestingly, upon HFD feeding, irradiated WT mice that received the bone marrow of AMPKα1-/- mice showed increased insulin resistance but not obesity, whereas irradiated AMPKα1-/- mice with WT bone marrow had a phenotype of metabolic dysregulation that was similar to that of global AMPKα1-/- mice. AMPKα1 deficiency in macrophages markedly increased the macrophage proinflammatory status. In addition, AMPKα1 knockdown enhanced adipocyte lipid accumulation and exacerbated the inflammatory response and insulin resistance. Together, these data show that AMPKα1 protects mice from diet-induced obesity and insulin resistance, demonstrating that AMPKα1 is a promising therapeutic target in the treatment of the metabolic syndrome.",
author = "Weiyu Zhang and Xianling Zhang and Huan Wang and Xin Guo and Honggui Li and Ying Wang and Xin Xu and Lyhun Tan and Mashek, {Mara T.} and Chunxiang Zhang and Yingjie Chen and Mashek, {Douglas G.} and Marc Foretz and Chuhong Zhu and Huaijun Zhou and Xu Liu and Benoit Viollet and Chaodong Wu and Yuqing Huo",
year = "2012",
month = "12",
day = "1",
doi = "10.2337/db11-1373",
language = "English (US)",
volume = "61",
pages = "3114--3125",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "12",

}

TY - JOUR

T1 - AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity

AU - Zhang, Weiyu

AU - Zhang, Xianling

AU - Wang, Huan

AU - Guo, Xin

AU - Li, Honggui

AU - Wang, Ying

AU - Xu, Xin

AU - Tan, Lyhun

AU - Mashek, Mara T.

AU - Zhang, Chunxiang

AU - Chen, Yingjie

AU - Mashek, Douglas G.

AU - Foretz, Marc

AU - Zhu, Chuhong

AU - Zhou, Huaijun

AU - Liu, Xu

AU - Viollet, Benoit

AU - Wu, Chaodong

AU - Huo, Yuqing

PY - 2012/12/1

Y1 - 2012/12/1

N2 - AMP-activated protein kinase (AMPK) is an essential sensor of cellular energy status. Defects in the α2 catalytic subunit of AMPK (AMPKα1) are associated with metabolic syndrome. The current study investigated the role AMPKα1 in the pathogenesis of obesity and inflammation using male AMPKα1-deficent (AMPKα1-/-) mice and their wild-type (WT) littermates. After being fed a high-fat diet (HFD), global AMPKα1 -/- mice gained more body weight and greater adiposity and exhibited systemic insulin resistance and metabolic dysfunction with increased severity in their adipose tissues compared with their WT littermates. Interestingly, upon HFD feeding, irradiated WT mice that received the bone marrow of AMPKα1-/- mice showed increased insulin resistance but not obesity, whereas irradiated AMPKα1-/- mice with WT bone marrow had a phenotype of metabolic dysregulation that was similar to that of global AMPKα1-/- mice. AMPKα1 deficiency in macrophages markedly increased the macrophage proinflammatory status. In addition, AMPKα1 knockdown enhanced adipocyte lipid accumulation and exacerbated the inflammatory response and insulin resistance. Together, these data show that AMPKα1 protects mice from diet-induced obesity and insulin resistance, demonstrating that AMPKα1 is a promising therapeutic target in the treatment of the metabolic syndrome.

AB - AMP-activated protein kinase (AMPK) is an essential sensor of cellular energy status. Defects in the α2 catalytic subunit of AMPK (AMPKα1) are associated with metabolic syndrome. The current study investigated the role AMPKα1 in the pathogenesis of obesity and inflammation using male AMPKα1-deficent (AMPKα1-/-) mice and their wild-type (WT) littermates. After being fed a high-fat diet (HFD), global AMPKα1 -/- mice gained more body weight and greater adiposity and exhibited systemic insulin resistance and metabolic dysfunction with increased severity in their adipose tissues compared with their WT littermates. Interestingly, upon HFD feeding, irradiated WT mice that received the bone marrow of AMPKα1-/- mice showed increased insulin resistance but not obesity, whereas irradiated AMPKα1-/- mice with WT bone marrow had a phenotype of metabolic dysregulation that was similar to that of global AMPKα1-/- mice. AMPKα1 deficiency in macrophages markedly increased the macrophage proinflammatory status. In addition, AMPKα1 knockdown enhanced adipocyte lipid accumulation and exacerbated the inflammatory response and insulin resistance. Together, these data show that AMPKα1 protects mice from diet-induced obesity and insulin resistance, demonstrating that AMPKα1 is a promising therapeutic target in the treatment of the metabolic syndrome.

UR - http://www.scopus.com/inward/record.url?scp=84870349122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870349122&partnerID=8YFLogxK

U2 - 10.2337/db11-1373

DO - 10.2337/db11-1373

M3 - Article

C2 - 22829451

AN - SCOPUS:84870349122

VL - 61

SP - 3114

EP - 3125

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 12

ER -